Details for 2013722217

Up to date per 03.04.2026

Actions

Title / Product Name

SOLUBILISIERTE KAPSELFORMULIERUNG VON 1,1-DIMETHYLETHYL-[(1S)-1-{[(2S,4R)-4-(7-CHLOR-4METHOXYISOCHINOLIN-1-YLOXY)-2-({(1R,2S)-1-[(CYCLOPROPYLSULFONYL)CARBAMOYL]-2-ETHENYLCYCLOPROPYL}CARBAMOYL)PYRROLIDIN-1-YL]CARBONYL}-2,2-DIMETHYLPROPYL]CARBAMAT

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2013722217

EP Publication Number

2846780

E-Number

1018614

Language

PCT Number

US13038770

Publication Date

18.03.2015 A

18.07.2018 B1

Registration Date

18.07.2018

AT Publication Date

15.08.2018

Application Date

30.04.2013

Registration Number

Priorities

07.05.2012

201261643454 P

IPC

A61K 9/48 20060101AFI20131126BHEP

Maximum Duration of Protection

30.04.2033

Owner

BRISTOL-MYERS SQUIBB HOLDINGS IRELAND UNLIMITED COMPANYHinterbergstraße 166312 SteinhausenCH

Representative

Häupl & Ellmeyer KG PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT

Inventor

PERRONE, Robert Kevinc/o Bristol-Myers Squibb Company 1 Squibb Drive New Brunswick, New Jersey 08903US